What: The FDA approved a pad from Qvin that doubles as a way to test the blood. The pad includes a removable strip that can be sent to a lab for analysis.
Why it matters: The pad is designed to help measure blood sugar averages over three months, to aid in diabetes management.
Source: FemTech Insider
Studies reinforce that HRT timing may affect Alzheimer’s risk.
A study identifies patterns in postpartum blood pressure that could help predict future hypertension.
Ashley Parker writes about the emotional and medical realities of miscarriage, including how the term “abortion” appears in routine procedures.
WNYC highlights 100 years of birth control in America.
BCG highlights a $100B opportunity in treating common women’s health conditions.
University of Calgary researchers found that female mice release leptin, a hormone associated with heightened pain sensitivity, which may explain why women experience more pain.
The Trump administration has frozen federal family-planning grants, affecting groups like Planned Parenthood.
World Economic Forum explores why improving diagnostics in women’s health is key.
Pregnant federal workers lose jobs and face insurance gaps.
The New York Times’ Wirecutter recommends tools to alleviate menopause symptoms, from cooling sheets to strength training equipment.
The New York Times dives into the ethics and limitations of using polygenic screening in IVF, highlighting the probabilistic nature of the predictions.
Rutgers researchers preserve and expand the Camden Study data.
A study from Intermountain Health finds heart outcome disparities between men and women are decreasing — but gaps in care remain.
Study shows over 50% of women don’t receive follow-up after cervical dysplasia treatment.
The U.S. Supreme Court appears inclined to allow Medicaid patients to continue receiving non-abortion care from Planned Parenthood.
Trump nominee Dave Weldon dropped out of CDC nomination after Sen. Murkowski raised concerns over his vaccine skepticism.
Context reports on the censorship faced by women’s health companies from Big Tech, with many ads rejected or content taken down.
Mass layoffs hit federal health agencies, eliminating offices focused on vulnerable populations and raising alarms over public health preparedness.
A Stanford economist study found that women who sought menopause treatment made 10% less income four years later.
A systematic review found laser treatments improve menopause symptoms but do not enhance tissue quality.